Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check3 days agoChange DetectedAdds IPD sharing policy details, including the plan to share individual participant data, access criteria, and time frames, along with related links and identifiers. This expansion provides information on how de-identified data may be requested and shared with qualified researchers.SummaryDifference88%

- Check10 days agoChange DetectedA new revision label, v3.6.5, was added and the previous label v3.6.4 was removed. This updates the page's revision metadata but does not change the study content or functionality.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays revision v3.6.4, replacing v3.6.3, indicating a small update to the page's content or presentation.SummaryDifference0.0%

- Check46 days agoChange DetectedThe study record gains two new Japan cross-reference identifiers: JapicCTI-194697 and jRCT2080224625. It also updates the record with a newer revision tag (Revision: v3.6.3) and recent dates, reflecting metadata enhancements to the entry.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision: v3.6.2 was added, replacing the previous v3.6.0. This represents a minor metadata update with no changes to study data or functionality.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now communicates that no participants are being enrolled for this rollover study and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting changes and the revision version are updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.